If Roche wants a truly revolutionary diagnostics firm to acquire they should acquire Trovagene. TROV figured out how to diagnose and monitor cancer and infectious diseases in urine. Their first urine based cancer test is launching in Jan 2013 with many more being rolled out in 2013. TROV being brought forward by elite scientists, dr's, professors and the whole old management team from Sequenom just took over the company. They have 40+ patents approved and 50+ pending for diagnosing cancer and diseases in urine. They also do transplant monitoring in urine and prenatal analysis using urine. They have been working on this for 10 years and are commercializing now. TROV will be acquired super quick I predict bc they are a game changer.
You are crazy. Trov figured out how to diagnose cancer in urine. They can also diagnose infectious diseases in urine. TROV has just an $88 mil market cap. I think its going straight to $25 a share so they will have $400-$500 mil market cap and will still be a small cap. I love both trov and sgyp
He might have tp raise his target if the bid study does well. Maybe $25 is too low? I like how irwd's drug is derived from a bacterial toxin that gives people travelers diarrhea . Way tl find a new drug. Sgyp is a peptide made tp look like the hormone and tp fit in the receptors. Sgyp's drug is going to normalize bowl movements while irwd's over shoots IMHO
he also said the collisto merger was to "clean up the capital structure". people assume they did this to prep for buyout
ceo says their drug is very stable after taken in intestine/digestive tract
ceo just said that irwd's drug over shoots the goal of curing constipation bc its a toxin originally identified in bacteria that gives people travelers diarhea (something like that)...they think SGYP's better acts to normalize bowel movements (something like that)
ceo says safety is a 'hallmark' of their drug and this class of drugs bc it acts locally, is not absorbed into the blood, no exposure to other organs, etc....super safe folks
ceo saying very exciting time for sgyp. says their constipation drug is in a class of drugs that will be making a huge impact on people...bbbuuullliiisssshhhh
started sounding very bullish...
hey dbaa....set up a phony email acct and post the address here. I will email you the aegis reports so you will shut up. 20-30 page reports of exceptional professionalism from ram selvaraju
The investor presentation on the trovagene website ir page really is impressive. The CEO talks for 30 minutes about why trove is a game changer for molecular diagnostics. People should check it out. I see vrng popping to $4.75 after the file lawsuit against Microsoft and yahoo
keep lying and committing fraud. maybe someone will come knock on your door. they have plenty of money to complete the current trial, they have shares they can sell at any time to raise money, they did a huge successful private placement last year and can do another after the shares are $10-$15. they wouldnt be rolling out new trials if they were concerned about money. I bet they sell 25% of the company for $500 mil early next year and the stock goes to $25